Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.12 USD | +0.30% | -0.33% | -9.99% |
05/06 | Catalyst Pharmaceuticals Insider Sold Shares Worth $276,735, According to a Recent SEC Filing | MT |
30/05 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.99% | 178.12Cr | |
+2.97% | 9.47TCr | |
-3.68% | 3.73TCr | |
-12.17% | 3.27TCr | |
+74.21% | 2.77TCr | |
-14.14% | 1.62TCr | |
-2.42% | 1.39TCr | |
-12.21% | 1.16TCr | |
+188.83% | 1.09TCr | |
-53.94% | 954.09Cr |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.
- Transcript : Catalyst Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 10, 2022